Objective To test whether autologous modified mesenchymal stem cells (MSCs) improve
recovery in patients with chronic major stroke. Methods In this prospective, open-label …

There may be the potential to improve stroke recovery with mesenchymal stem cells (MSCs);
however, questions about the efficacy and safety of this treatment remain. To address these …

Background: Cell transplantation is a 'hype and hope'in the current scenario. It is in the early
stage of development with promises to restore function in chronic diseases. Mesenchymal …

While preclinical stroke studies have shown that mesenchymal stem cells (MSCs) promote
recovery, few randomized controlled trials (RCT) have assessed cell therapy in humans. In …

Mesenchymal stem cell (MSC) transplantation improves recovery from ischemic stroke in
animals. We examined the feasibility, efficacy, and safety of cell therapy using culture …

Exogenous stem cell therapy (SCT) has been recognized recently as a promising
neuroregenerative strategy to augment recovery in stroke survivors. Mesenchymal stem …

Background and Purpose: Stem cell–based therapy is a promising approach to repair brain
damage after stroke. This study was conducted to investigate changes in neuroimaging …

Background and Purpose—Stroke is a leading cause of long-term disability. Limited
treatment options exist for patients with chronic stroke and substantial functional deficits. The …

We previously evaluated the short-term follow-up preliminary data of mesenchymal stem
cells (MSCs) transplantation in patients with ischemic stroke. The present study was …

Bone marrow-derived mesenchymal stem cells (MSCs) have great potential as therapeutic
agents in stroke management, since they are easily accessible and can be rapidly …